Difficulty: Medium
Average Score: 86%
Practice
Which of the following antidepressants has significant alfa2-adrenoreceptor antagonism?
Correct answer
C
Rationale
The correct answer is C) Mirtazapine. Mirtazapine is known for its significant alpha2-adrenoreceptor antagonism. This pharmacological property contributes to its unique mechanism of action as an antidepressant. By blocking alpha2-adrenoreceptors, mirtazapine enhances the release of norepinephrine and serotonin in the brain, leading to its therapeutic effects in depression.
A) Amitriptyline is a tricyclic antidepressant that primarily acts by inhibiting the reuptake of norepinephrine and serotonin. It does not possess significant alpha2-adrenoreceptor antagonism like mirtazapine.
B) Nefazodone is a serotonin modulator and stimulator that primarily works by selectively inhibiting serotonin reuptake. It does not exhibit significant alpha2-adrenoreceptor antagonism.
D) Doxepin is a tricyclic antidepressant that primarily acts by inhibiting the reuptake of norepinephrine and serotonin. It does not have significant alpha2-adrenoreceptor antagonism as seen with mirtazapine.
Understanding the pharmacological properties of different antidepressants is crucial in selecting the most appropriate medication for individual patients. Safety pharmacology across the lifespan involves considering the unique physiological differences and potential risks associated with drug therapy in patients of different age groups. This knowledge is vital for healthcare professionals to ensure safe and effective treatment outcomes for patients with depression.
A) Amitriptyline is a tricyclic antidepressant that primarily acts by inhibiting the reuptake of norepinephrine and serotonin. It does not possess significant alpha2-adrenoreceptor antagonism like mirtazapine.
B) Nefazodone is a serotonin modulator and stimulator that primarily works by selectively inhibiting serotonin reuptake. It does not exhibit significant alpha2-adrenoreceptor antagonism.
D) Doxepin is a tricyclic antidepressant that primarily acts by inhibiting the reuptake of norepinephrine and serotonin. It does not have significant alpha2-adrenoreceptor antagonism as seen with mirtazapine.
Understanding the pharmacological properties of different antidepressants is crucial in selecting the most appropriate medication for individual patients. Safety pharmacology across the lifespan involves considering the unique physiological differences and potential risks associated with drug therapy in patients of different age groups. This knowledge is vital for healthcare professionals to ensure safe and effective treatment outcomes for patients with depression.